The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Zepbound (tirzepatide) is only available on prescription for people with obesity, or those with overweight. Learn how to get Zepbound online, in-person, and through the drug’s manufacturer, Eli ...

Newly-launched obesity company Kailera Therapeutics has announced the appointment of Jamie Coleman as chief commercial ...

Lilly Investors have listed Zepbound for $1,086.37 per fill. But the actual costs will vary depending on each patient's insurance coverage of prescription drugs. Those who have commercial drug ...

In a recent press release, Eli Lilly's management said that the U.S. incretin market, which includes drugs like Zepbound and Mounjaro, didn't grow as fast as it anticipated in the fourth quarter.

She joins Kailera from Eli Lilly where she held key roles in brand strategy, consumer marketing, and global commercial ...

Commercial insurers and employers were previously hesitant to cover the drug due to its high cost of over $1,000 a month. Insurers can still choose not to cover Zepbound, despite the CMS's guidance.